Axon sells Optiscan stake
Monday, 16 February, 2004
Axon Instruments (ASX:AXN) has sold its majority shareholding in Optiscan Imaging (ASX:OIL) to JF Asset Management, the Hong Kong-based Jardine Fleming institutional investment group, one of the largest fund managers in the Asia Pacific region.
JF Asset Management bought 7.8 million shares, representing 9.7 per cent of the issued shares in the company, while the remainder of the 9.6 million shares held by Axon were sold to institutional investors in Australia.
Optiscan CFO Bruce Andrew said that Axon had been one of the founding shareholders of the company, and had also provided financial support prior to the company listing.
But as a listed company, Axon recently decided to divest itself of its holdings in Optiscan as the investment no longer fit with the strategic direction of the company.
"What we are pleased about is that the shares have found a home in what promises to be a long-term supporter of the company," Andrew said. "The sale of the shares represents the respect and sensitivity that Axon has for us."
In a statement, JF Asset Management said that the group's focus was on "small caps that offered significant upside through penetration of global markets".
Bird flu found in Victorian egg farm, returned traveller
Two separate instances of avian influenza (bird flu) were reported in Victoria yesterday —...
Cell-mapping project to uncover genetic fingerprints of disease
The $27m project will see researchers map 50 million human cells from 10,000 people to identify...
People with autism appear predisposed to PTSD
While recent studies in humans have highlighted the co-occurrence of ASD and PTSD, the link...